Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00364_DB02300> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00364_DB02300 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00364_DB02300 label "DDI between Sucralfate and Calcipotriol - Vitamin D Analogs may increase the serum concentration of Sucralfate. Specifically, the absorption of aluminum from sucralfate may be increased, leading to an increase in the serum aluminum concentration. Avoid chronic and/or excessive use of aluminum and aluminum-containing products (such as sucralfate) in patients who are also taking vitamin D analogs. Any patients consuming such a combination should be monitored closely for aluminum status and signs/symptoms of aluminum-related toxicities. [drugbank_resource:DB00364_DB02300]" assertion.
- drugbank_resource:DB00364_DB02300 identifier "drugbank_resource:DB00364_DB02300" assertion.
- drugbank_resource:DB00364_DB02300 title "DDI between Sucralfate and Calcipotriol - Vitamin D Analogs may increase the serum concentration of Sucralfate. Specifically, the absorption of aluminum from sucralfate may be increased, leading to an increase in the serum aluminum concentration. Avoid chronic and/or excessive use of aluminum and aluminum-containing products (such as sucralfate) in patients who are also taking vitamin D analogs. Any patients consuming such a combination should be monitored closely for aluminum status and signs/symptoms of aluminum-related toxicities." assertion.